AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across England and Wales.
AstraZeneca receives positive NICE recommendations for lung cancer treatment
- Post author:admin
- Post published:January 24, 2025
- Post category:uncategorized